Adult Immunization Indications Page 3

ADVERTISEMENT

Vaccine  
Indication/Recommendations  
Schedule  
Contraindications/Precautions  
Dosing/Administration  
MMR-­‐II  
Contraindications:  
Pts   b orn   i n   1 957   o r   l ater   ( especially   i f   b orn   o utside  
Give   1   o r   2   d oses   d epending   o n  
LIVE   V ACCINE  
 
the   U S)   s hould   r eceive   a t   l east   1   d ose   o f   M MR   i f  
indication  
Previous   a naphylactic   r eaction   t o   t his  
0.5   m L   S UB-­‐Q  
Measles,  
there   i s   n o   l ab   e vidence   o f   i mmunity   o r  
 
vaccine   o r   t o   a ny   o f   i ts   c omponents  
Store   i n   F REEZER  
st
Mumps,  
documentation   o f   a   d ose   g iven   o n   o r   a fter   t he   1
 
If   g iving   2   d oses,   s hould   s eparate  
including   g elatin   o r   n eomycin  
 
Rubella  
birthday  
by   a t   l east   4   w eeks  
Pregnancy   o r   t he   p ossibility   o f  
To   R econstitute:  
HIGH   R ISK   P ATIENTS-­‐   s hould   r eceive   2   d oses  
 
pregnancy   w ithin   4   w eeks  
6.
Withdraw   t he   e ntire  
Healthcare   p ersonnel   ( Paid,   U npaid,  
Within   7 2   h rs   o f   m easles   e xposure,  
Severe   i mmunodeficiency  
volume   o f   d iluent   i nto  
o
Volunteer)  
give   1   d ose   a s   p ostexposure  
Hematologic   a nd   s olid  
a   s yringe  
o
Students   e ntering   c ollege   a nd   o ther   p ost-­‐
prophylaxis   t o   s usceptible   a dults  
tumors  
7.
Inject   a ll   o f   t he  
o
high   s chool   e ducational   i nstitutions  
 
Receiving   C hemo  
diluent   i n   t he   s yringe  
o
International   t ravelers  
If   2   o r   m ore   l ive   v accine   a re   t o   b e   g iven  
Congenital  
into   t he   v ial   o f  
o
o
Pts   b orn   b efore   1 957   a re   u sually   c onsidered  
(FluMist,   M MR,   V aricella,   Z oster,  
Immunodeficiency  
lyophilized   v accine  
immune,   b ut   e vidence   o f   i mmunity   ( serology   o r  
and/or   Y ellow   F ever)   t hey   s hould   b e  
Long-­‐term  
8.
Gently   a gitate   t o   m ix  
o
documented   h istory   o f   2   d oses   o f   M MR)   s hould   b e  
given   o n   t he   s ame   d ay   O R   s paced   a part  
immunosuppressive   t herapy  
thoroughly   –   p roduct  
considered   f or   h ealthcare   p ersonnel  
by   a t   l east   2 8   d ays  
Severely   s ymptomatic   H IV  
should   b e   c lear   y ellow  
o
 
 
in   c olor  
Women   o f   c hildbearing   a ge   w ho   d o   n ot   h ave  
Note:   R outine   p ost-­‐vaccination  
NOTE:   H IV   i nfection   i s   N OT   a  
9.
Withdraw   t he   e ntire  
acceptable   e vidence   o f   r ubella   i mmunity   o r  
serologic   t esting   i s   n ot   r ecommended.  
contraindication   t o   M MR   f or   t hose   w ho  
contents   i nto   a   n ew  
vaccination   s hould   r eceive   v accine  
 
are   n ot   s everely   i mmunocompromised   ( i.e.  
syringe  
IF   p regnant   w oman   i s   f ound   t o   b e   r ubella  
CD4   ≥   2 00)  
10. Inject   t he   t otal  
susceptible,   g ive   1   d ose   o f   M MR   p ostpartum  
 
volume   ( about   0 .5  
Precautions:  
mL)   s ub-­‐q   i nto   o uter  
aspect   o f   u pper   a rm  
Moderate   o r   s evere   a cute   i llness  
(preferred   s ite)  
If   b lood,   p lasma,   a nd/or   i mmune  
 
globulin   w ere   g iven   i n   t he   p ast   1 1  
 
months,   s ee   a dditional   A CIP  
If   n ot   u sed   i mmediately,  
guidelines  
may   s tore   v accine   v ial   i n  
History   o f   t hrombocytopenia   o r  
dark   p lace   3 6   –   4 6   °   F   f or  
thrombocytopenic   p urpura  
up   t o   m ax   o f   8   h ours  
 
 
Note:   I f   T B   t est   a nd   M MR   a re   b oth   n eeded  
but   n ot   g iven   o n   t he   s ame   d ay,   d elay   T B  
test   f or   4   t o   6   w eeks   a fter   M MR  
Gardasil  
Contraindications:  
All   p reviously   u nvaccinated   w omen   t hrough   a ge   2 6  
3   d oses   a t   0 ,   2 ,   a nd   6   m onths  
0.5   m L   I M  
 
Previous   a naphylactic   r eaction   t o   t his  
 
Consider   g iving   H PV4   t o   m en   t hrough   a ge   2 6   t o  
Must   b e   a t   l east   4   w eeks   b etween  
HPV  
reduce   t heir   l ikelihood   o f   a cquiring   g enital   w arts  
dose   1   a nd   2  
vaccine   o r   t o   a ny   o f   i ts   c omponents  
If   p ossible   u se   t he   s ame  
including   y east,   a morphous   a luminum  
product   f or   a ll   3   d oses  
Must   b e   a t   l east   1 2   w eeks  
hydroxyphosphate   s ulfate,   o r  
between   d ose   2   a nd   3  
polysorbate   8 0  
Overall,   m ust   b e   a t   l east   2 4   w eeks  
 
between   d ose   1   a nd   3  
Precautions:  
 
Moderate   o r   s evere   a cute   i llness  
 
Pregnancy-­‐   d ata   i s   l imited   s o   d elay  
until   a fter   c ompletion   o f   t he  
pregnancy  
References:   A ll   i nformation   i s   f rom   e ither   t he   C DC   w ebsite   o r   t he   i ndividual   p roduct   p ackage   i nserts.    

ADVERTISEMENT

00 votes

Related Articles

Related forms

Related Categories

Parent category: Medical
Go
Page of 3